BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38721105)

  • 41. Current situation of viral hepatitis in Egypt.
    Elbahrawy A; Ibrahim MK; Eliwa A; Alboraie M; Madian A; Aly HH
    Microbiol Immunol; 2021 Sep; 65(9):352-372. PubMed ID: 33990999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes.
    Ito T; Nguyen MH
    J Hepatocell Carcinoma; 2023; 10():413-428. PubMed ID: 36926055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
    Hassan MM; Zaghloul AS; El-Serag HB; Soliman O; Patt YZ; Chappell CL; Beasley RP; Hwang LY
    J Clin Gastroenterol; 2001 Aug; 33(2):123-6. PubMed ID: 11468438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
    Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
    Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma.
    Xie X; Zheng M; Guo W; Zhou Y; Xiang Z; Li Y; Yang J
    Sci Rep; 2022 Aug; 12(1):13969. PubMed ID: 35978032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
    Doycheva I; Zhang T; Amjad W; Thuluvath PJ
    J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study.
    Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.
    Ziada DH; El Sadany S; Soliman H; Abd-Elsalam S; Salama M; Hawash N; Selim A; Hamisa M; Elsabagh HM
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):257-262. PubMed ID: 27378258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.
    Ezzat S; Abdel-Hamid M; Eissa SA; Mokhtar N; Labib NA; El-Ghorory L; Mikhail NN; Abdel-Hamid A; Hifnawy T; Strickland GT; Loffredo CA
    Int J Hyg Environ Health; 2005; 208(5):329-39. PubMed ID: 16217918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.
    Hester CA; Rich NE; Singal AG; Yopp AC
    J Natl Compr Canc Netw; 2019 Apr; 17(4):322-329. PubMed ID: 30959469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of liver cirrhosis over twenty consecutive years in adults in Southern China.
    Wang X; Luo JN; Wu XY; Zhang QX; Wu B
    World J Hepatol; 2023 Dec; 15(12):1294-1306. PubMed ID: 38223413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis.
    Crane H; Eslick GD; Gofton C; Shaikh A; Cholankeril G; Cheah M; Zhong JH; Svegliati-Baroni G; Vitale A; Kim BK; Ahn SH; Kim MN; Strasser S; George J
    Clin Mol Hepatol; 2024 Apr; ():. PubMed ID: 38623613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.
    Dyson J; Jaques B; Chattopadyhay D; Lochan R; Graham J; Das D; Aslam T; Patanwala I; Gaggar S; Cole M; Sumpter K; Stewart S; Rose J; Hudson M; Manas D; Reeves HL
    J Hepatol; 2014 Jan; 60(1):110-7. PubMed ID: 23978719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt.
    Abou El Azm AR; Yousef M; Mansour N; Awad A; El Dardiry S; Abdel Aziz I
    J Gastrointest Cancer; 2014 Sep; 45(3):276-83. PubMed ID: 24488435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
    Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
    J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.
    Gonzalez-Chagolla A; Olivas-Martinez A; Ruiz-Manriquez J; Servín-Rojas M; Kauffman-Ortega E; Chávez-García LC; Juárez-León O; Cordova-Gallardo J; Díaz-García JD; Gonzalez-Huezo MS; Milanés-Lizarraga G; Paez-Zayas VM; Castillo-Barradas M; Cobos-Quevedo OJ; García-Juárez FI; Romero-Lozanía JA; Toapanta-Yanchapaxi L; Sánchez-Avila JF; Avila-Rojo JA; Bonilla-Salas A; Dirthurbide-Hernández M; Ruiz I; Valenzuela-Vidales AK; García-Juárez I
    Lancet Reg Health Am; 2022 Mar; 7():100151. PubMed ID: 36777654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
    Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
    World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.